Core Viewpoint - Blackrock Silver Corp. is initiating a fully-funded 20,000-metre drill program at its Tonopah West project, aiming to enhance its mineral resource estimates and expand its silver and gold inventory [1][2][3]. Drilling Program Details - The drill program will commence in July 2024, utilizing two core drills from Alloy Drilling, LLC and one reverse circulation drill from Legacy Drilling, LLC [2]. - The program has two main objectives: converting approximately one million tonnes of high-grade silver and gold from inferred to measured and indicated resource categories, and connecting the DPB zone to the NW target area [4][5]. Resource Conversion Focus - The resource conversion will target high grades within the Bermuda and Merten vein systems, with drilling planned on 25-metre centers over an area of 270 metres East-West and 550 metres North-South [4]. - A total of 12,000 metres of combined reverse circulation and core drilling is planned for this portion of the program [4]. Resource Expansion Efforts - The expansion drilling will focus on a 1-kilometre vein corridor between the DPB and NW Step-out deposits, with a total of 8,000 metres of drilling planned [5]. - Eleven holes are planned for this resource expansion, including nine new pre-collars and two existing pre-collars [5]. Metallurgical Test Work - The company has engaged Kappes, Cassidy & Associates to conduct additional metallurgical test work, with results expected in August 2024 [6]. - This test work aims to refine estimated metallurgical recoveries and assist in recommending processing parameters and capital expenditures [6]. Company Background - Blackrock Silver Corp. is focused on precious metal exploration, with a proven track record and a portfolio that includes significant silver and gold resources [9]. - The company controls a 100% interest in its Nevada properties, which are known for low-sulphidation, epithermal gold and silver mineralization [9].

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. BRC is quite a good fit in this regard, gaining 13.6% over this period. Looking at the fundamentals, the stock currently carries a Zac ...

Company Overview - IXOPAY has appointed Brady Harris as its new CEO following its merger with TokenEx, marking a significant shift towards a multi-processor payment model in the payments industry [1][2] - The company aims to become a one-stop solution in the payment industry, offering services such as omnichannel tokenization, payment orchestration, and card lifecycle management [3][6] Leadership and Experience - Brady Harris brings over 20 years of experience in FinTech, Payments, and SaaS, previously serving as CEO of Dwolla, where he increased annual payment volumes from $10 billion to $70 billion [2][3] - Under Harris's leadership, IXOPAY is expected to set new benchmarks in the payment sector, focusing on scalability, security, and innovative advancements [5] Industry Trends and Innovations - The merger with TokenEx allows IXOPAY to enhance its capabilities in payment processing and security, addressing the limitations of single-processor systems [3][6] - IXOPAY is positioned to lead advancements in payments technology, integrating tokenization and orchestration to support multi-payment processing and foster innovative services [4][5] Upcoming Events - IXOPAY will showcase its expanded offerings at Money 20/20 Europe in Amsterdam, highlighting advancements in payment orchestration, tokenization, risk management, and card lifecycle management [5]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. In order to see if BRC is a promising momen ...

Brady (BRC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Indivi ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, ...

MILWAUKEE, May 24, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) ("Brady" or "Company") announced that Christopher Hix will join its Board of Directors, effective May 24, 2024. "Chris' extensive financial and strategic experience as a leader at several industrial companies, where he played a key role in accelerating growth, makes him an outstanding addition to the Brady Board of Directors," said Bradley C. Richardson, Chair of Brady's Board of Directors. Mr. Hix joins the Brady Board of Directors a ...

Core Insights - Brady Corporation has appointed Christopher Hix to its Board of Directors effective May 24, 2024, bringing extensive experience in financial leadership and strategic growth [1][2]. Group 1: Christopher Hix's Background - Mr. Hix has a 39-year career in public companies across various global markets, including serving as CFO of Enovis Corporation from 2016 to 2022, where he led the transformation to medical technologies [2]. - He held the CFO position at OM Group, Inc. from 2012 until its acquisition in late 2015, and at Robbins & Myers from 2006 to 2011, during significant expansion [2]. - Hix has also spent 14 years in various roles at Roper Industries, contributing to its growth and transition to public ownership [2]. - He served on the Board of Directors of ESAB Corporation from 2021 to 2024, a company with $3 billion in revenue [2]. Group 2: Educational Background - Mr. Hix holds an MBA from St. Mary's College of California and a Bachelor of Science in Business Administration from the University of Southern California [3]. - He earned his public accounting certification early in his career [3]. Group 3: Strategic Vision for Brady - Hix emphasized Brady's commitment to profitable growth through innovation, R&D, technology investments, and strategic M&A to enhance shareholder value [4]. - The Chair of Brady's Board of Directors highlighted Hix's extensive financial and strategic experience as a key asset for accelerating growth [4]. - Brady's President and CEO noted that Hix's experience in leading high-technology global businesses and M&A will be invaluable for pursuing long-term growth opportunities [5]. Group 4: Company Overview - Brady Corporation is an international manufacturer and marketer of solutions that enhance safety, security, productivity, and performance, with a diverse product range including labels, signs, safety devices, and software [6]. - Founded in 1914, Brady serves various industries such as electronics, telecommunications, manufacturing, and medical, employing approximately 5,600 people as of July 31, 2023 [6]. - The company's fiscal 2023 sales were approximately $1.33 billion, and its stock trades on the New York Stock Exchange under the symbol BRC [6].

Financial Data and Key Metrics Changes - The company reported a record high earnings per share (EPS) of $1.05, up 9.4% year-over-year, with non-GAAP EPS increasing 14.7% to $1.09 [14][15] - Organic sales growth was 4.5%, with total sales growth of 1.9% after accounting for foreign currency translation and divestitures [16][18] - Gross profit margin improved to 51.6%, an increase of 130 basis points from the previous year [19] Business Line Data and Key Metrics Changes - The Americas and Asia region saw organic sales growth of 4.5%, while Europe and Australia experienced 4.4% growth [16][34] - Segment profit in the Americas and Asia increased by 1% to $49.7 million, maintaining a profit margin of 22.1% [36] - In Europe, segment profit rose 14.3% from $17.1 million to $19.5 million, driven by strong organic sales growth [37] Market Data and Key Metrics Changes - The company noted a decline in sales in China by over 17%, but growth in other markets like India and Singapore compensated for this drop [49] - The healthcare segment has been a drag on organic growth, with stagnant hospital admissions impacting performance [68][105] Company Strategy and Development Direction - The company is focused on launching innovative products, with several new products introduced this quarter, including a rugged barcode scanner and an industrial inkjet printer [9][52] - There is an ongoing commitment to return funds to shareholders through dividends and share buybacks, with $61.6 million returned this quarter [17][32] - The company is investing in research and development, increasing R&D spending from $15.7 million to $17.7 million [21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for the second half of the year, despite uncertainties in the economic environment [43][65] - The company expects low single-digit organic sales growth for the full fiscal year 2024, with guidance adjusted for EPS [24][47] - Management highlighted the potential of generative AI to enhance productivity and sales effectiveness [12] Other Important Information - The company has a strong cash position with $96.7 million in net cash and plans for disciplined capital allocation [31][32] - The company has increased its dividend for 38 consecutive years, reflecting a commitment to shareholder returns [23][92] Q&A Session Summary Question: What trends are being seen in industrial automation and healthcare? - Management noted hesitancy in investment in industrial automation due to economic concerns, while the healthcare segment has been stagnant but new products are expected to improve performance [44][68] Question: How did the company achieve organic growth in Europe? - The company attributed growth to increased product consumption rather than pricing, with successful expansion in wallet share among customers [61][107] Question: What surprised management in the quarter? - Management was surprised by the acceleration of product adoption in the last month of the quarter, indicating a shift in customer purchasing behavior [80][88]

Financial Performance - Net sales for the three months ended April 30, 2024 increased 1.9% to $343.4 million compared to $337.1 million in the same period in the prior year, with organic sales growth of 4.5%[97] - Gross margin increased 4.3% to $177.0 million in the three months ended April 30, 2024, with a gross margin percentage of 51.6%, up from 50.3% in the prior year[99] - Operating income for the three months ended April 30, 2024 was $63.5 million, or 18.5% of net sales, compared to $63.0 million, or 18.7% in the prior year[96] - Net income for the three months ended April 30, 2024, was $50.9 million, a 14.8% increase from $48.1 million in the same period last year; for the nine months, net income rose to $141.8 million, up 12.9% from $125.5 million[114] - Operating income increased by 0.9% to $63.5 million for the three months ended April 30, 2024, and by 8.6% to $177.2 million for the nine months ended April 30, 2024, compared to the same periods in the prior year[113] Expenses - Research and development expenses increased 12.5% to $17.7 million in the three months ended April 30, 2024, representing 5.1% of net sales[111] - Selling, general and administrative expenses increased 5.3% to $95.8 million in the three months ended April 30, 2024, with SG&A as a percentage of sales rising to 27.9%[100] Cash and Liquidity - The Company had cash of $160.5 million and total available liquidity of $1,245.0 million as of April 30, 2024[83] - Cash and cash equivalents were $160.5 million as of April 30, 2024, an increase of $8.9 million from July 31, 2023, primarily due to improved profitability and reduced inventory spend[122] - Net cash provided by operating activities was $171.1 million for the nine months ended April 30, 2024, compared to $129.9 million in the same period last year, reflecting improved profitability[122] - The company believes that net cash provided by operating activities will continue to be adequate to meet liquidity and capital needs over the next 12 months and beyond[140] Sales Growth - Organic sales growth for the nine months ended April 30, 2024 was 3.0%, contributing to a net sales increase of 1.2% to $998.0 million[98] - Americas & Asia net sales increased 0.9% to $224.8 million in the three months ended April 30, 2024, with organic sales growth of 4.5%[104] - Organic sales growth in the Americas was 4.5% for the three months and 3.0% for the nine months ended April 30, 2024, driven by strong performance in safety and facility identification product lines[117] - Organic sales in Europe increased by 4.4% for the three months ended April 30, 2024, with strong growth in safety and facility identification product lines, particularly in France and Germany[119] Dividends - The Company declared a quarterly cash dividend of $0.235 per share payable on July 31, 2024[90] Risks and Challenges - The Company expects to continue experiencing inflationary pressures and supply chain disruptions through the end of fiscal 2024, but has been able to mitigate impacts through pricing actions[108] - The company faces risks including increased costs of raw materials, decreased demand for products, and supply chain disruptions[143] - The company must effectively compete and execute its strategy to develop technologically advanced products that meet customer demands[143] - The company is subject to extensive regulations by U.S. and non-U.S. governmental entities, which may impact operations[143] - The company may face litigation risks, including product liability claims[143] - The company is exposed to foreign currency fluctuations and potential write-offs of goodwill and other intangible assets[143] Financial Agreements and Compliance - The outstanding balance on the Company's credit agreement was $63.8 million as of April 30, 2024, with a maximum outstanding amount of $64.7 million during the nine months[127] - The Company maintained a debt to EBITDA ratio of 0.2 to 1.0 and an interest expense coverage ratio of 98.1 to 1.0 as of April 30, 2024, in compliance with financial covenants[128] - The company entered into an amendment to the credit agreement on December 21, 2021, to adjust to alternative benchmarks due to the elimination of LIBOR[141] Internal Controls and Market Risk - There were no changes in the company's internal control over financial reporting that materially affected its financial reporting[155] - There has been no material change in market risk information since the 2023 Form 10-K[154] - There are no significant agreements for the purchase of inventory or other goods or services specifying minimum order quantities[140]